Authors
Loading...
Experimental validation and network pharmacology analysis demonstrate icariin's ability to reduce atherosclerosis in mice, indicating multi-target therapeutic potential.
Song et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: